Lista de obras -

A Phase 1, Open Label- Assessment of a Dengue Virus-1 Live Virus Human Challenge - (DENV-1-LVHC) Strain

artículo científico publicado en 2020

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

artículo científico publicado en 2007

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

artículo científico publicado en 2015

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults

artículo científico publicado en 2012

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques

artículo científico publicado en 2015

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

artículo científico publicado en 2005

Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1

artículo científico publicado en 2020

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

artículo científico publicado en 2019

Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies

artículo científico publicado en 2008

Dengue Virus Exposures Among Deployed U.S. Military Personnel

artículo científico publicado en 2017

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

artículo científico publicado en 2003

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

artículo científico publicado en 2017

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines

artículo científico publicado en 2012

Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines

artículo científico publicado en 2003

Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase I Randomized Clinical Trial

scientific article published on 23 September 2020

Immunological Assays used to Support Efficacy of Zika Virus Vaccines

scientific article published on 28 June 2019

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

artículo científico publicado en 2011

Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

artículo científico publicado en 2016

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

artículo científico publicado en 2003

Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques

artículo científico publicado en 2009

Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States

artículo científico publicado en 2017

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

artículo científico publicado en 2009

Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico

artículo científico publicado en 2018

Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine

artículo científico publicado en 2003

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

artículo científico publicado en 2020

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

artículo científico publicado en 2017

Production and testing of dengue virus strains suitable for human infection studies

artículo científico publicado en 2014

Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.

artículo científico publicado en 2003

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

artículo científico publicado en 2006

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

artículo científico publicado en 2016

Rapid development of a DNA vaccine for Zika virus

artículo científico publicado en 2016

Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study

scientific article published on 02 March 2020

Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial

artículo científico publicado en 2015

Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants ⬇️

artículo científico publicado el 1 de agosto de 2011

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

scientific article published on 27 April 2020

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

artículo científico publicado en 2020

Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial

artículo científico publicado en 2014

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.

artículo científico publicado en 2008

Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates

artículo científico publicado en 2003

Vaccine protection against Zika virus from Brazil

artículo científico publicado en 2016

Lista de obras de

A Phase 1, Open Label- Assessment of a Dengue Virus-1 Live Virus Human Challenge - (DENV-1-LVHC) Strain

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico

A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1

Cell-mediated immune responses to different formulations of a live-attenuated tetravalent dengue vaccine candidate in subjects living in dengue endemic and non-endemic regions

Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies

Dengue Virus Exposures Among Deployed U.S. Military Personnel

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines

Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines

Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase I Randomized Clinical Trial

Immunological Assays used to Support Efficacy of Zika Virus Vaccines

Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate

Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques

Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico

Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Production and testing of dengue virus strains suitable for human infection studies

Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command.

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Rapid development of a DNA vaccine for Zika virus

Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study

Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial

Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants ⬇️

Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Safety and immunogenicity of a rederived, live-attenuated dengue virus vaccine in healthy adults living in Thailand: a randomized trial

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.

Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates

Vaccine protection against Zika virus from Brazil